Summary (tl;dr)

The U.S. Food and Drug Administration (FDA) has announced the results of its most extensive testing to date, affirming that the U.S. infant formula supply is safe with undetectable or very low levels of chemical contaminants.

Essential Background

The safety of infant formula has been a significant public concern, particularly following the widespread 2022 recall by Abbott Nutrition due to contamination with Cronobacter sakazakii and Salmonella Newport at its Sturgis, Michigan facility, which led to infant illnesses and deaths. This event, along with subsequent recalls in 2023 by other manufacturers like Reckitt, Perrigo, and ByHeart for similar contamination concerns, intensified regulatory scrutiny and prompted the FDA to launch initiatives such as "Operation Stork Speed" and "Closer to Zero." These initiatives aim to enhance oversight, expand testing, and reduce infants' exposure to environmental contaminants in their food supply.

The Full Story

Today, the FDA released the findings from its "largest and most rigorous" examination of chemical contaminants in infant formula sold in the U.S. market. Conducted between 2023 and 2025 as part of "Operation Stork Speed," the agency tested over 300 samples from 16 brands, encompassing powdered, liquid concentrate, and ready-to-feed formulas. The testing targeted a range of contaminants, including heavy metals (lead, arsenic, cadmium, mercury), pesticides, phthalates, and per- and polyfluoroalkyl substances (PFAS), also known as "forever chemicals." The FDA's report concludes that the overwhelming majority of samples showed undetectable or very low levels of these substances, thereby affirming the safety of the U.S. infant formula supply. While low levels of some contaminants were detected in certain samples, these were generally well below established safety limits, and the FDA has indicated it will pursue additional testing and work with manufacturers to further minimize contaminant levels. This comprehensive report coincides with the FDA's ongoing efforts to conduct the first full review of infant formula nutrient requirements since 1998.

Why It Matters

These trending keywords and the FDA's latest announcement are significant as they offer crucial reassurance to parents and caregivers who depend on infant formula for their babies' nutritional needs. The comprehensive nature of the testing and the transparency of the results are designed to restore and maintain confidence in the safety of the U.S. infant formula market, especially in the wake of past contamination incidents and supply chain disruptions. The FDA's continued commitment to rigorous oversight, ongoing monitoring, and active engagement with manufacturers underscores a dedication to protecting the health of infants and ensuring a safe and reliable food supply.

Geographic Location

• Sturgis, St. Joseph County, Michigan, United States (Abbott Nutrition manufacturing facility linked to the 2022 recall that spurred increased scrutiny)
• Washington, D.C., District of Columbia, United States (Location of the U.S. Department of Health and Human Services and FDA, where the results were announced and policy decisions are made)